- Home
- CRBU vs CLBR Comparison
CRBU vs CLBR Comparison
Compare CRBU & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- CLBR
- Stock Information
- Founded
- CRBU 2011
- CLBR 2023
- Country
- CRBU United States
- CLBR United States
- Employees
- CRBU N/A
- CLBR N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- CLBR
- Sector
- CRBU Health Care
- CLBR
- Exchange
- CRBU Nasdaq
- CLBR Nasdaq
- Market Cap
- CRBU 236.3M
- CLBR 222.7M
- IPO Year
- CRBU 2021
- CLBR 2023
- Fundamental
- Price
- CRBU $1.98
- CLBR $10.62
- Analyst Decision
- CRBU Strong Buy
- CLBR
- Analyst Count
- CRBU 3
- CLBR 0
- Target Price
- CRBU $14.00
- CLBR N/A
- AVG Volume (30 Days)
- CRBU 1.9M
- CLBR 186.7K
- Earning Date
- CRBU 11-06-2024
- CLBR 01-01-0001
- Dividend Yield
- CRBU N/A
- CLBR N/A
- EPS Growth
- CRBU N/A
- CLBR N/A
- EPS
- CRBU N/A
- CLBR N/A
- Revenue
- CRBU $11,475,000.00
- CLBR N/A
- Revenue This Year
- CRBU N/A
- CLBR N/A
- Revenue Next Year
- CRBU N/A
- CLBR N/A
- P/E Ratio
- CRBU N/A
- CLBR $135.79
- Revenue Growth
- CRBU N/A
- CLBR N/A
- 52 Week Low
- CRBU $1.50
- CLBR $9.16
- 52 Week High
- CRBU $8.33
- CLBR $10.65
- Technical
- Relative Strength Index (RSI)
- CRBU 43.48
- CLBR 85.61
- Support Level
- CRBU $2.37
- CLBR $10.51
- Resistance Level
- CRBU $2.08
- CLBR $10.65
- Average True Range (ATR)
- CRBU 0.26
- CLBR 0.06
- MACD
- CRBU -0.07
- CLBR 0.03
- Stochastic Oscillator
- CRBU 6.42
- CLBR 92.86
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.